{
    "Trade/Device Name(s)": [
        "GLUCOLABTM Blood Glucose Monitoring System",
        "GLUCOLABTM Diabetes Monitoring System",
        "GLUCOLABTM"
    ],
    "Submitter Information": "Infopia Co., Ltd.",
    "510(k) Number": "K051285",
    "Predicate Device Reference 510(k) Number(s)": [
        "K024194",
        "K984261",
        "K021513"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW",
        "JJX"
    ],
    "Summary Letter Date": "AUG 2-2005",
    "Summary Letter Received Date": "May 17, 2005",
    "Submission Date": "May 16, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "POCT"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GLUCOLABTM Monitor",
        "GLUCOLABTM Test Strips"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection",
        "Dehydrogenase glucose reaction"
    ],
    "Methodologies": [
        "Electrochemical assay"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Test Strip",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Infopia GLUCOLABTM Blood Glucose Monitoring System for quantitative glucose measurement in whole blood",
    "Indications for Use Summary": "Quantitative measurement of glucose in whole blood for monitoring diabetes management in home, clinical, point of care settings; plasma-equivalent results; not for neonatal blood; supports alternate site testing.",
    "fda_folder": "Clinical Chemistry"
}